| Q45324934 | A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice. |
| Q33694750 | Adaptive evolution of proteins in hepatitis B virus during divergence of genotypes |
| Q51776495 | Anti-preS responses influence the anti-HBs response in newborns after vaccination with the third generation Sci-B-Vac vaccine. |
| Q27693188 | Applications of human hepatitis B virus preS domain in bio- and nanotechnology |
| Q55395370 | Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations. |
| Q31161563 | Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China |
| Q40836583 | Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines |
| Q36099102 | Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein |
| Q82044308 | Combined pre‐S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case‐control study in China |
| Q40163226 | Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion |
| Q40889515 | Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. |
| Q45399734 | Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B. |
| Q42947874 | Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay. |
| Q37267283 | Different pre-S deletion patterns and their association with hepatitis B virus genotypes |
| Q42507635 | Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. |
| Q45733499 | Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease |
| Q56898698 | Genome-wide characterisation of hepatitis B mutations involved in clinical outcome |
| Q34807240 | Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies. |
| Q52584501 | Hepatitis B virus pre-S/S variants in liver diseases. |
| Q45413516 | Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus |
| Q35010703 | Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins |
| Q45375652 | Molecular and clinical characteristics of hepatitis B virus in Korea |
| Q41251653 | Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production |
| Q34651625 | Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China |
| Q37082600 | PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac vaccine and their relation to the antibody response to hepatitis B surface antigen |
| Q45381994 | Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant |
| Q40604966 | Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes |
| Q33661054 | Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma |
| Q40397531 | T cell recognition of hepatitis B and C viral antigens |